DA32 Life Science Tech Acquisition Corp.
DALSDelisted Jul 28, 2023- Industry
- Blank Checks
- SEC CIK
- 0001863294
DA32 Life Science Tech Acquisition Corp. was delisted on Jul 28, 2023; its insiders filed their last Form 4 on Aug 10, 2023; 51 institutions reported holding it in 13F filings for Q2 2023, worth $174.9M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 51
- Q2 2023, +1 vs. previous quarter
- 13F value
- $174.9M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding DALS, Q2 2023
No superinvestor reported holding DALS at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by DA32 Life Science Tech Acquisition Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing)9:47 PM ET | Jul 30 | 4 days | Maris William J and 2 othersDirector, 10% Owner, Other: Director by Deputization | PPurchaseClass A Common Stock | +800.0K | $10.00 | +$8.00M | New position800.0K after | |
| Aug 3, 2021 (view filing)9:06 PM ET | Jul 30 | 4 days | Nelsen Robert and 5 others10% Owner | PPurchaseClass A Common Stock | +1.60M | $10.00 | +$16.0M | New position1.60M after | Duplicate filing |
| Aug 3, 2021 (view filing)8:27 PM ET | Jul 30 | 4 days | Deerfield Management Company, L.P. and 3 othersDirector, 10% Owner, Other: Director by Deputization | PPurchaseClass A Common Stock | +1.60M | $10.00 | +$16.0M | New position1.60M after | Duplicate filing |
| Aug 3, 2021 (view filing) | Jul 30 | 4 days | Crandell KeithDirector, 10% Owner | PPurchaseClass A Common Stock | +1.60M | $10.00 | +$16.0M | New position1.60M after | |
| Aug 3, 2021 (view filing) | Jul 30 | 4 days | DA32 Sponsor LLC10% Owner | PPurchaseClass A Common Stock | +650.0K | $10.00 | +$6.50M | New position650.0K after |
Top 10 13F holders, Q2 2023
The largest institutional positions in DA32 Life Science Tech Acquisition Corp. at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivaldi Asset Management, LLC | 2,355,502 | $24.2M | 1.44% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,600,000 | $16.4M | 0.35% | 00.0% | Unchanged |
| BlackRock Inc. | 1,500,000 | $15.4M | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 1,240,593 | $12.7M | 0.42% | −17,684−1.4% | Reduced |
| Periscope Capital Inc. | 1,182,558 | $12.1M | 0.95% | +72,756+6.6% | Added |
| Moore Capital Management, LP | 750,000 | $7.70M | 0.19% | 00.0% | Unchanged |
| Millennium Management LLC | 714,100 | $7.33M | 0.01% | −40,000−5.3% | Reduced |
| Magnetar Financial LLC | 655,522 | $6.73M | 0.15% | −258,217−28.3% | Reduced |
| Citadel Advisors LLC | 584,130 | $5.99M | 0.01% | −143,192−19.7% | Reduced |
| Janus Henderson Group PLC | 430,000 | $4.42M | 0.00% | 00.0% | Unchanged |